"We estimate there are several hundred unapproved drugs out there, " said Deborah Autor, director of the office of compliance within the FDA's Center for Drug Evaluation and Research.
In 2004, an evaluation carried out by the University of Oxford concluded that the threat of losing benefits made little difference to compliance with community sentences.